20.5 C
New York
Thursday, June 18, 2026

Tag: Objective

newssourceFORcompanyinformationcontent1marketreleases

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

-         The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in...

Debuts of All-new SIXPACK Charger Scat Pack and HEMI®-powered Durango SRT Hellcat Jailbreak Highlight Decade of MotorTrend Presents Roadkill Nights Powered by Dodge

AUBURN HILLS, Mich., Aug. 12, 2025 /PRNewswire/ -- ...

Undervalued Gold Equities Poised for a Breakout

Equity Insider News CommentaryIssued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ -- Late last week as global equities rose,...

Undervalued Gold Equities Poised for a Breakout

Equity Insider News CommentaryIssued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ -- Late last week as global equities rose,...

Undervalued Gold Equities Poised for a Breakout

Equity Insider News CommentaryIssued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, Aug. 12, 2025 /CNW/ -- Late last week as global equities rose,...

Blockmate investee Hivello integrates with Theta Network to boost user earnings

TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Blockmate Ventures Inc. (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH) (“Blockmate” or the “Company”) is pleased to announce that its investee, Hivello Holdings, has successfully integrated DePIN Theta Network with the Hivello platform to increase passive income earning opportunities for Hivello users.

Tradr Launches First-to-Market Leveraged ETFs on Datadog & Astera Labs

Two new 2X long single-stock funds focused on AI-enabling infrastructure names NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for...

Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results

LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the second quarter ended June 30, 2025.

Cineplex Reports Second Quarter 2025 Results

TORONTO, Aug. 12, 2025 /CNW/ - (TSX: CGX) - Today, Cineplex Inc. ("Cineplex" or the "Company") released its financial results for the three and six...

FORTUNE BAY PROVIDES CORPORATE UPDATE AND OUTLINES PROGRESS ACROSS GOLD PORTFOLIO

Strategic Milestones Ahead as Fortune Bay Advances Cycle-Aligned Gold Assets HALIFAX, NS, Aug. 12, 2025 /CNW/ - Fortune Bay Corp. (TSXV: FOR) (FWB: 5QN) (OTCQB:...

Orla Mining Reports Second Quarter 2025 Financial Results

VANCOUVER, BC, Aug. 11, 2025 /CNW/ - Orla Mining Ltd. (TSX: OLA) (NYSE: ORLA) ("Orla" or the "Company") today announces the results for the...

NGEx Reports Q2 2025 Results; Porphyry and High-grade Gold Discoveries at Lunahuasi; Plan to Spin-out Royalties to Shareholders

VANCOUVER, BC, Aug. 11, 2025 /CNW/ - NGEx Minerals Ltd. ("NGEx Minerals" "NGEx" or the "Company") (TSX: NGEX) (OTCQX: NGXXF) is pleased to report...

Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue

Ninepoint Partners LP Announces Voting Results for Changes to Investment Objective and Other Changes for Ninepoint Resource Fund

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (Ninepoint Partners) announced today the voting results following the special meeting of unitholders of Ninepoint Resource Fund (the Fund).

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsObjective

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers